i2a SA
Company

Last deal

Amount

Venture - Series Unknown

Stage

27.11.2013

Date

1

all rounds

General

About Company
i2a is a diagnostic and medical informatics company.

Industry

Sector :

Subsector :

founded date

01.01.1988

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

With expertise in microbiology, robotics, and computer science, i2a addresses all laboratory needs by offering instrumentation, software, and consumables. The company is known for its SirScan antibacterial antibiotic testing, SirWeb Bacteriology Validation System, and Epidemiology Software. i2a equips about 75% of hospitals in France and is a leading partner in bacteriology, continuously adapting its products to user preferences to drive development and innovation.
Contacts